Hyseq Pharmaceuticals, Inc. is engaged in research and development of novel biopharmaceutical products from its collection of proprietary genes discovered using its high-throughput screening-by-hybridization platform. This platform provided a significant advantage in discovering novel, rarely- expressed genes, and assembly of one of the most important proprietary databases of full-length human gene sequences. Hyseq intends to further elucidate the physiological roles of its proprietary novel genes. Hyseq's database includes genes which encode a number of therapeutically important classes of molecules including chemokines, growth factors, stem cell factors, interferons, integrins, proteases, hormones, receptors, and other potential protein therapeutics or drug targets.
View Top Employees from Hyseq , Inc.Website | http://www.hyseq.com |
Revenue | $14 million |
Employees | View employees |
Address | 670 Almanor Ave, Sunnyvale, California 94085, US |
Phone | (408) 524-8100 |
Industry | Biotechnology, Pharmaceuticals, Healthcare |
Competitors | HudsonAlpha Institute for Biotechnology, Lexicon Pharmaceuticals, Inc., Quark Pharmaceuticals Inc, UAB Valentis |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Hyseq , Inc. employee's phone or email?
The Hyseq , Inc. annual revenue was $14 million in 2023.
Hyseq , Inc. is based in Sunnyvale, California.
The NAICS codes for Hyseq , Inc. are [3254, 325, 32].
The SIC codes for Hyseq , Inc. are [283, 28, 80].